Cited by 2,310Rheumatoid Arthritis Research and TherapiesGenetic Associations and EpidemiologyNatural Compounds in Disease Treatment

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Open access
the RACI consortium, Okada, Yukinori, the GARNET consortium, Wu, Di, Trynka, Gosia, Raj, Towfique, Terao, Chikashi, Ikari, Katsunori +89 more·2014·Nature

Abstract

A major challenge in human genetics is to devise a systematic strategy to integrate disease-associated variants with diverse genomic and biological data sets to provide insight into disease pathogenesis and guide drug discovery for complex traits such as rheumatoid arthritis (RA). Here we performed a genome-wide association study meta-analysis in a total of >100,000 subjects of European and Asian ancestries (29,880 RA cases and 73,758 controls), by evaluating ∼10 million single-nucleotide polymorphisms. We discovered 42 novel RA risk loci at a genome-wide level of significance, bringing the total to 101 (refs 2 - 4). We devised an in silico pipeline using established bioinformatics methods based on functional annotation, cis-acting expression quantitative trait loci and pathway analyses--as well as novel methods based on genetic overlap with human primary immunodeficiency, haematological cancer somatic mutations and knockout mouse phenotypes--to identify 98 biological candidate genes at these 101 risk loci. We demonstrate that these genes are the targets of approved therapies for RA, and further suggest that drugs approved for other indications may be repurposed for the treatment of RA. Together, this comprehensive genetic study sheds light on fundamental genes, pathways and cell types that contribute to RA pathogenesis, and provides empirical evidence that the genetics of RA can provide important information for drug discovery.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature12873

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • GWAS, meta-analysis, exome analysis and SNP mapping have associated IL-6, IL-6R and gp130 with inflammatory diseases such as RA and coronary artery disease.

    “Genome-wide association studies (GWAS), meta-analysis, exome analysis and single nucleotide polymorphism (SNP) mapping have associated IL-6, IL-6R and gp130 with inflammatory diseases such as RA and coronary artery disease (263–269).”

    From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [268]

    The paper’s Abstract (page unavailable) reports a GWAS meta-analysis of rheumatoid arthritis risk loci and identifies the IL-6R-targeting drug tocilizumab among therapies linked to its RA genetics analysis. It does not establish the claimed genetic associations for IL-6, IL-6R and gp130 across both RA and coronary artery disease, or report exome analysis supporting them. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. [1]Plenge RM Scolnick EM Altshuler D Validating therapeutic targets through human genetics Nat Rev Drug Discov 2013 12 581 594 23868113
  2. [2]Stahl EA Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci Nat Genet 2010 42 508 514 20453842 PMC4243840
  3. [3]Okada Y Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population Nat Genet 2012 44 511 516 22446963
  4. [4]Eyre S High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis Nat Genet 2012 44 1336 1340 23143596 PMC3605761
  5. [6]Westra HJ Systematic identification of trans eQTLs as putative drivers of known disease associations Nat Genet 2013 45 1238 1243 24013639 PMC3991562
  6. [7]Raychaudhuri S Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions PLoS Genet 2009 5 e1000534 19557189 PMC2694358
  7. [8]Rossin EJ Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology PLoS Genet 2011 7 e1001273 21249183 PMC3020935
  8. [9]Segre AV Groop L Mootha VK Daly MJ Altshuler D Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits PLoS Genet 2010 6 e1001058 20714348 PMC2920848
  9. [10]Stahl EA Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis Nat Genet 2012 44 483 489 22446960 PMC6560362
  10. [12]Raychaudhuri S Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis Nat Genet 2012 44 291 296 22286218 PMC3288335
  11. [13]Trynka G Chromatin marks identify critical cell types for fine mapping complex trait variants Nat Genet 2013 45 124 130 23263488 PMC3826950
  12. [14]Parvaneh N Casanova JL Notarangelo LD Conley ME Primary immunodeficiencies: a rapidly evolving story J Allergy Clin Immunol 2013 131 314 323 23374262
  13. [15]Forbes SA COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer Nucleic Acids Res 2011 39 D945 D950 20952405 PMC3013785
  14. [16]Eppig JT Blake JA Bult CJ Kadin JA Richardson JE The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse Nucleic Acids Res 2012 40 D881 D886 22075990 PMC3245042
  15. [17]Knox C DrugBank 3.0: a comprehensive resource for ‘omics’ research on drugs Nucleic Acids Res 2011 39 D1035 D1041 21059682 PMC3013709
  16. [18]Zhu F Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery Nucleic Acids Res 2012 40 D1128 D1136 21948793 PMC3245130
  17. [19]Smolen JS Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions Ann Rheum Dis 2013 72 482 492 23172750 PMC3595138
  18. [20]Nishimoto N Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy Mod Rheumatol 2009 19 12 19 18979150 PMC2638601
  19. [22]Sekine C Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors J Immunol 2008 180 1954 1961 18209094
  20. [23]Sanseau P Use of genome-wide association studies for drug repositioning Nat Biotechnol 2012 30 317 320 22491277
  21. [24]Arnett FC The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 1988 31 315 324 3358796
  22. [25]Okada Y Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations Nat Genet 2012 44 904 909 22797727 PMC4737645
  23. [27]Lage K A human phenome-interactome network of protein complexes implicated in genetic disorders Nat Biotechnol 2007 25 309 316 17344885
  24. [28]Ueda H Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 2003 423 506 511 12724780
  25. [29]Elliott P Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease JAMA 2009 302 37 48 19567438 PMC2803020
  26. [30]Cortes A Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci Nat Genet 2013 45 730 738 23749187 PMC3757343

Cited by

Sorted by citations

Authors
the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., Suzuki, A., Yoshida, S., Graham, R. R., Manoharan, A., Ortmann, W., Bhangale, T., Denny, J. C., Carroll, R. J., Eyler, A. E., Greenberg, J. D., Kremer, J. M., Pappas, D. A., Jiang, L., Yin, J., Ye, L., Su, D.-F., Yang, J., Xie, G., Keystone, E., Westra, H.-J., Esko, T., Metspalu, A., Zhou, X., Gupta, N., Mirel, D., Stahl, E. A., Diogo, D., Cui, J., Liao, K., Guo, M. H., Myouzen, K., Kawaguchi, T., Coenen, M. J. H., van Riel, P. L. C. M., van de Laar, M. A. F. J., Guchelaar, H.-J., Huizinga, T. W. J., Dieudé, P., Mariette, X., Louis Bridges Jr, S., Zhernakova, A., Toes, R. E. M., Tak, P. P., Miceli-Richard, C., Bang, S.-Y., Lee, H.-S., Martin, J., Gonzalez-Gay, M. A., Rodriguez-Rodriguez, L., Rantapää-Dahlqvist, S., Ärlestig, L., Choi, H. K., Kamatani, Y., Galan, P., Lathrop, M., Eyre, S., Bowes, J., Barton, A., de Vries, N., Moreland, L. W., Criswell, L. A., Karlson, E. W., Taniguchi, A., Yamada, R., Kubo, M., Liu, J. S., Bae, S.-C., Worthington, J., Padyukov, L., Klareskog, L., Gregersen, P. K., Raychaudhuri, S., Stranger, B. E., De Jager, P. L., Franke, L., Visscher, P. M., Brown, M. A., Yamanaka, H., Mimori, T., Takahashi, A., Xu, H., Behrens, T. W., Siminovitch, K. A., Momohara, S., Matsuda, F., Yamamoto, K., & Plenge, R. M.
Affiliations
  • Broad Institute (US)
  • Kyoto University (JP)
  • Tokyo Women's Medical University (JP)
  • RIKEN (JP)
  • Genentech (US)
  • Vanderbilt University (US)
  • New York University Langone Orthopedic Hospital (US)
  • Center for Rheumatology (US)
  • NewYork–Presbyterian Hospital (US)
  • Second Military Medical University (CN)
  • Translational Research Institute (AU)
  • Mount Sinai Hospital (CA)
  • University Medical Center Groningen (NL)
  • University of Tartu (EE)
  • Beijing Jiaotong University (CN)
  • Icahn School of Medicine at Mount Sinai (US)
  • Radboud University Medical Center (NL)
  • Leiden University Medical Center (NL)
  • Inserm (FR)
  • University of Cambridge (GB)
  • Hanyang University Seoul Hospital (KR)
  • Consejo Superior de Investigaciones Científicas (ES)
  • Umeå University (SE)
  • Boston University (US)
  • Fondation Jean Dausset-CEPH (FR)
  • McGill University and Génome Québec Innovation Centre (CA)
  • National Health Service (GB)
  • Manchester Academic Health Science Centre (GB)
  • University of Pittsburgh (US)
  • University of California, San Francisco (US)
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • Karolinska Institutet (SE)
  • Northwell Health (US)
  • University of Chicago (US)
Corresponding author
  • Okada, Yukinori
  • Plenge, Robert M.
Venue
Nature
Published
2013-12-25
Volume
506
Issue
7488
Pages
376-381
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1989590412
Cited by
2,310
References
4
Citations by year
2026: 84 · 2025: 129 · 2024: 201 · 2023: 186 · 2022: 229 · 2021: 249 · 2020: 193 · 2019: 195 · 2018: 196 · 2017: 185 · 2016: 195 · 2015: 178 · 2014: 83 · 2013: 1 · 2012: 1
FWCI
124.92
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • University of Twente Research Information (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • University of Twente Research Information (submittedVersion)
Funders
  • GlaxoSmithKline
  • Brigham and Women's Hospital
  • School of Medicine, Boston University
  • University of Pittsburgh
  • McGill University
  • Génome Québec
  • National Institute for Health and Care Research (MANMKBRU-2012-1)
  • Institut National de la Santé et de la Recherche Médicale
  • Ministry of Education, Culture, Sports, Science and Technology
  • Rijksuniversiteit Groningen
  • National Natural Science Foundation of China (81273283, 30972339)
  • Universiteit van Amsterdam
  • Hanyang University
  • Science and Technology Commission of Shanghai Municipality
  • Umeå Universitet
  • ReumaNederland
  • Medical Research Council Canada
  • Université Paris-Sud
  • Université Paris 13
  • Assistance publique-Hôpitaux de Paris
  • Versus Arthritis (20385)
  • National Institutes of Health (5r01ar063759-07, R01‐AR‐063759)
  • U.S. Public Health Service (K08-KAR055688A)
  • Canadian Institutes of Health Research (79321)
  • Medical Research Council
  • National Health and Medical Research Council
  • Japan Society for the Promotion of Science (24390360, 221S0001, 22133008, 23229007, 24592285, 26460649, 25293225)
  • Instituto de Salud Carlos III
  • National Key Research and Development Program of China (2011CB946100)
  • National Heart, Lung, and Blood Institute (U19HL065962)
  • National Institute of General Medical Sciences (U01GM092691)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (K08AR060257, R01-AR-063759-01A1, R21AR056042, R01AR059648, R01AR056768, R01AR057108, P60AR047785, K24AR052403, R01AR056291, R01AR065944, R01-AR063759)
  • U.S. National Library of Medicine (T15LM007450)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords
rheumatoid arthritis, genetic susceptibility loci, drug repurposing, drug discovery, functional annotation, expression quantitative trait loci, pathway analysis, somatic mutations, pathogenesis
MeSH terms
Alleles, Animals, Arthritis, Rheumatoid, Female, Humans, Male, Case-Control Studies, Mice, Knockout, Computational Biology, Hematologic Neoplasms, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Asian People, Mice, Genome-Wide Association Study, Drug Discovery, Drug Repositioning, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review